¹¹C/¹⁸F-labeled inhibitors of glycogen synthase kinase-3

摘要

The present invention relates to new ¹¹C/¹⁸F-labeled inhibitor compounds for over-expressed GSK-3 prepared from the GMP synthesis method. The present invention provides novel ¹¹C/¹⁸F inhibitor compounds for over-expressed GSK-3 that are suitable for use as an in vivo imaging agent. A pharmaceutical comprising the compound and a kit for the preparation of the pharmaceutical are also provided.